M Estela Rubio-Gozalbo Selected Research

Galactose (Galactopyranose)

1/2020	Pathophysiology and targets for treatment in hereditary galactosemia: A systematic review of animal and cellular models.
1/2020	Nucleotide sugar profiles throughout development in wildtype and galt knockout zebrafish.
11/2018	Arginine does not rescue p.Q188R mutation deleterious effect in classic galactosemia.
1/2018	Impaired fertility and motor function in a zebrafish model for classic galactosemia.
1/2018	Intrafamilial oocyte donation in classic galactosemia: ethical and societal aspects.
9/2017	Classic Galactosemia: Study on the Late Prenatal Development of GALT Specific Activity in a Sheep Model.
1/2017	Sweet and sour: an update on classic galactosemia.
1/2017	International clinical guideline for the management of classical galactosemia: diagnosis, treatment, and follow-up.
3/2015	White matter microstructure pathology in classic galactosemia revealed by neurite orientation dispersion and density imaging.
1/2014	Revised proposal for the prevention of low bone mass in patients with classic galactosemia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Estela Rubio-Gozalbo Research Topics

Disease

19	Galactosemias (Galactosemia) 01/2020 - 11/2006
11	Phenylketonurias (Phenylketonuria) 01/2022 - 02/2003
2	Cataract (Cataracts) 01/2021 - 02/2015
2	Brain Diseases (Brain Disorder) 01/2021 - 02/2015
2	Metabolic Diseases (Metabolic Disease) 01/2020 - 01/2017
2	Primary Ovarian Insufficiency 01/2020 - 01/2013
2	Movement Disorders (Movement Disorder) 01/2020 - 02/2015
2	Infertility (Sterility) 01/2018 - 09/2013
2	Osteoporosis 01/2017 - 10/2013
2	Congenital Abnormalities (Deformity) 01/2014 - 01/2008
1	Melanoma (Melanoma, Malignant) 01/2022
1	Tyrosinemias (Tyrosinemia) 01/2022
1	Disease Susceptibility (Diathesis) 01/2021
1	Hemorrhage 01/2021
1	Multiple Acyl Coenzyme A Dehydrogenase Deficiency 01/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2018
1	Cognitive Dysfunction 01/2017
1	Metabolic Bone Diseases (Osteopenia) 01/2017
1	Adenoma (Adenomas) 01/2017
1	Hepatorenal form of glycogen storage disease 01/2017
1	Disease Progression 01/2016
1	Leukemia 02/2015
1	Intellectual Disability (Idiocy) 02/2015
1	Atrophy 02/2015
1	Neutropenia 02/2015
1	Ketosis 11/2014
1	Malnutrition (Nutritional Deficiencies) 01/2014
1	Osteoporotic Fractures 10/2013
1	Medium chain acyl CoA dehydrogenase deficiency 05/2012
1	Congenital Disorders of Glycosylation 04/2011
1	Dihydropyrimidine Dehydrogenase Deficiency 06/2009
1	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 01/2008
1	Necrotizing Enterocolitis 08/2007
1	Hypogonadism (Hypergonadotropic Hypogonadism) 12/2006

Drug/Important Bio-Agent (IBA)

13	Galactose (Galactopyranose)FDA LinkGeneric 01/2020 - 11/2006
8	EnzymesIBA 01/2020 - 11/2006
5	Phenylalanine (L-Phenylalanine)FDA Link 01/2022 - 02/2003
5	galactose-1-phosphateIBA 01/2020 - 01/2017
4	sapropterin (tetrahydrobiopterin)FDA Link 01/2018 - 02/2003
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 10/2013
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2016
2	Arginine (L-Arginine)FDA Link 11/2018 - 08/2007
2	Essential Fatty AcidsIBA 01/2018 - 01/2017
2	MicronutrientsIBA 01/2018 - 01/2017
2	CalciumIBA 01/2014 - 11/2006
2	Hormones (Hormone)IBA 09/2013 - 04/2009
2	Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA 01/2013 - 02/2003
2	Protein Isoforms (Isoforms)IBA 04/2011 - 01/2008
2	Insulin-Like Growth Factor Binding Protein 3IBA 01/2008 - 12/2006
1	Glucosamine (Dona)IBA 01/2022
1	Cytidine Monophosphate (CMP)IBA 01/2022
1	Tyrosine (L-Tyrosine)FDA Link 01/2022
1	Transaminases (Aminotransferases)IBA 01/2021
1	Polysaccharides (Glycans)IBA 01/2020
1	AntioxidantsIBA 01/2020
1	GalactokinaseIBA 01/2020
1	UTP-Glucose-1-Phosphate Uridylyltransferase (UDP Glucose Pyrophosphorylase)IBA 01/2020
1	Uridine Diphosphate Glucose (UDP Glucose)IBA 01/2020
1	Uridine Diphosphate Galactose (UDP Galactose)IBA 01/2020
1	UridineIBA 01/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	Amino Acids FDA Link 01/2019
1	Recombinant ProteinsIBA 11/2018
1	arginine aspartateIBA 11/2018
1	Lactose FDA LinkGeneric 01/2018
1	Uric Acid (Urate)IBA 01/2017
1	Triglycerides (Triacylglycerol)IBA 01/2017
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2017
1	CholesterolIBA 01/2017
1	Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA 01/2017
1	3-methylglutaconic acidIBA 02/2015
1	Messenger RNA (mRNA)IBA 02/2015
1	Ketone BodiesIBA 11/2014
1	KetonesIBA 11/2014
1	Vitamin D FDA LinkGeneric 01/2014
1	plastinIBA 10/2013
1	Actins (F Actin)IBA 10/2013
1	Testosterone (Sustanon)FDA Link 09/2013
1	inhibin BIBA 09/2013
1	GonadotropinsIBA 01/2013
1	Acyl-CoA Dehydrogenase (Medium-Chain Acyl-Coenzyme A Dehydrogenase)IBA 05/2012
1	Congenital disorder of glycosylation type 1AIBA 04/2011
1	phosphomannomutaseIBA 04/2011
1	Fluorouracil (Carac)FDA LinkGeneric 06/2009
1	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 06/2009
1	pyrimidineIBA 06/2009
1	Antineoplastic Agents (Antineoplastics)IBA 06/2009
1	Ligases (Synthetase)IBA 08/2007
1	Carbamyl Phosphate (Carbamoyl Phosphate)IBA 08/2007
1	Thyroxine (Levothyroxine)FDA LinkGeneric 12/2006
1	Insulin-Like Growth Factor I (IGF-1)IBA 12/2006
1	Glycoproteins (Glycoprotein)IBA 12/2006
1	Cholecalciferol (Vitamin D3)FDA Link 11/2006

Therapy/Procedure

1	Complementary Therapies (Alternative Medicine) 01/2020
1	Diet Therapy (Therapy, Diet) 01/2018
1	Precision Medicine 01/2017
1	Therapeutics 01/2016
1	Medical Day Care (Partial Hospitalization) 03/2015
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2014